Cargando…
A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer
BACKGROUND: Early diagnosis of pancreatic ductal adenocarcinoma (PDAC) is difficult due to the lack of effective screening tests. CA199, the standard biomarker for PDAC management, is not sufficiently reliable for early diagnosis. This prospective study aimed to evaluate whether circulating tumor ce...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102772/ https://www.ncbi.nlm.nih.gov/pubmed/35334495 http://dx.doi.org/10.1002/jcla.24341 |